<DOC>
	<DOC>NCT00249067</DOC>
	<brief_summary>This is a retrospective chart review examining our experience with carvedilol in CHF secondary to left-to-right heart shunt lesions. The treatment group will be children who have received carvedilol. The control or comparison groups will be patients who have received either digoxin/furosemide or captopril for this indication. Charts will be reviewed of patients who have been treated at Children’s Healthcare of Atlanta and as outpatients by Sibley Heart Center Cardiology between September 2000 and October 2005. Patients will have been started on carvedilol prior to April 1, 2005 and only information up to October 1, 2005 will be used for this study. We will review approximately 50 charts for this study. We will evaluate the effectiveness of these medications at reducing symptoms of CHF.</brief_summary>
	<brief_title>Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients</brief_title>
	<detailed_description>This is a retrospective chart review examining our experience with carvedilol in CHF secondary to left-to-right heart shunt lesions. The treatment group will be children who have received carvedilol. The control or comparison groups will be patients who have received either digoxin/furosemide or captopril for this indication. Charts will be reviewed of patients who have been treated at Children’s Healthcare of Atlanta and as outpatients by Sibley Heart Center Cardiology between September 2000 and October 2005. Patients will have been started on carvedilol prior to April 1, 2005 and only information up to October 1, 2005 will be used for this study. We will review approximately 50 charts for this study. We will evaluate the effectiveness of these medications at reducing symptoms of CHF.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Murmurs</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Captopril</mesh_term>
	<criteria>Children aged 018 years with a cardiac defect resulting in a lefttoright shunt (i.e. ventricular septal defect) who develop congestive heart failure. Patient must have been treated with one of the study medications: carvedilol, digoxin, or furosemide. Patients who are not between 018, who do not have a defect resulting in lefttoright shunt, who do not have congestive heart failure and who have not been treated with one of the study medications: carvedilol, digoxin, or furosemide.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Congestive Heart Failure, Left-to-Right Shunt</keyword>
</DOC>